pharmaceutical companies in South Korea as of H1 2021.
In 2021, GC Pharma's net profit amounted to around 137 billion South Korean won, up from around 89.3 billion won in the previous year. GC Pharma is also known as Green Cross and recorded the third-largest revenue among Net profit of GC Pharma (Green Cross Corporation) from 2015 to 2021 (in billion South Korean won)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 USD $39 USD / Month *
in the first 12 months
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Statistics on Pharma and biotech M&A activity
Industry overview
5
- Premium Statistic Pharmaceutical market: worldwide revenue 2001-2022
- Premium Statistic Global biotech drug sales 2012-2022
- Premium Statistic Top 10 biotech and pharmaceutical companies based on market cap 2022
- Premium Statistic Top 50 pharmaceutical companies - Rx sales and R&D spending 2021
- Premium Statistic Top pharmaceutical companies by capex growth in 2021
Number of deals
7
- Premium Statistic Planned and actual healthcare and life sciences activity in 2020, by subsector
- Premium Statistic Global number of life sciences sector deals 2013-2021
- Premium Statistic Number of biopharmaceutical deals worldwide 2016-2020, by type
- Basic Statistic Number of cell and gene therapy deals worldwide 2016-2020, by type
- Premium Statistic Number of biopharma M&A deals worldwide 2010-2019, by companies
- Basic Statistic Number of biopharma M&A deals worldwide 2010-2019, by total transaction value
- Premium Statistic Number of biopharma M&A deals worldwide 2010-2019, by industry
Value of deals
5
- Premium Statistic Largest M&A pharmaceutical deals ever as of 2023
- Premium Statistic Global value of life sciences sector deals 2013-2021
- Basic Statistic Top completed life sciences deals based on value globally 2020
- Premium Statistic Value of biopharma M&A deals worldwide 2010-2019, by industry
- Premium Statistic Average value of biopharma M&A deals worldwide 2010-2019, by industry
Mega-merger: BMS/Celgene
5
- Premium Statistic Bristol-Myers Squibb's revenue 2006-2021
- Basic Statistic Bristol-Myers Squibb revenue by segment 2015-2020
- Basic Statistic Celgene's revenue and net income 2006-2018
- Premium Statistic Revenue of Celgene 2016-2018, by therapeutic area
- Premium Statistic Top pharma companies worldwide 2022, by size of R&D pipeline
2021 outlook
4
- Basic Statistic Expected acquisitions of biopharma companies by type of asset 2021
- Basic Statistic Expected investment in biopharma and diagnostic lab services 2021, by type
- Basic Statistic Expected valuation changes in healthcare and life sciences 2021, by subsector
- Premium Statistic Expected investment changes in biopharma and diagnostic lab services 2021
Further related statistics
15
- Market share of Celltrion's Remsima in Europe Q1 2015-Q2 2018
- Market share of Celltrion's Truxima in Europe Q2 2017-Q2 2018
- Celltrion R&D investment South Korea 2013-2017
- Biosimilar market size Japan 2018-2030
- Biopharmaceutical market size forecast Japan 2011-2020
- Biopharmaceuticals revenue in Latin America 2022-2027
- Share of Novo Nordisk in insulin market in Greater China 2019, by segment
- Employment in pharma industry in Colombia 2014-2020
- Number of applications for drug reimbursement in Denmark 2013-2021
- Revenue forecast for global biologics market 2016-2022
- VECOL S.A.: net sales breakdown 2016-2018, by segment
- Yuhan's sales revenue from non-prescription drugs 2016-2021
- Pharmaceuticals production value in Colombia 2014-2020
- VECOL S.A.: net income 2016-2018
- Italy: market value of medical biological products 2017, by molecule
Further Content: You might find this interesting as well
Statistics
- Market share of Celltrion's Remsima in Europe Q1 2015-Q2 2018
- Market share of Celltrion's Truxima in Europe Q2 2017-Q2 2018
- Celltrion R&D investment South Korea 2013-2017
- Biosimilar market size Japan 2018-2030
- Biopharmaceutical market size forecast Japan 2011-2020
- Biopharmaceuticals revenue in Latin America 2022-2027
- Share of Novo Nordisk in insulin market in Greater China 2019, by segment
- Employment in pharma industry in Colombia 2014-2020
- Number of applications for drug reimbursement in Denmark 2013-2021
- Revenue forecast for global biologics market 2016-2022
- VECOL S.A.: net sales breakdown 2016-2018, by segment
- Yuhan's sales revenue from non-prescription drugs 2016-2021
- Pharmaceuticals production value in Colombia 2014-2020
- VECOL S.A.: net income 2016-2018
- Italy: market value of medical biological products 2017, by molecule
DART. (March 21, 2022). Net profit of GC Pharma (Green Cross Corporation) from 2015 to 2021 (in billion South Korean won) [Graph]. In Statista. Retrieved March 20, 2023, from https://www.statista.com/statistics/1165955/gc-pharma-net-profit/
DART. "Net profit of GC Pharma (Green Cross Corporation) from 2015 to 2021 (in billion South Korean won)." Chart. March 21, 2022. Statista. Accessed March 20, 2023. https://www.statista.com/statistics/1165955/gc-pharma-net-profit/
DART. (2022). Net profit of GC Pharma (Green Cross Corporation) from 2015 to 2021 (in billion South Korean won). Statista. Statista Inc.. Accessed: March 20, 2023. https://www.statista.com/statistics/1165955/gc-pharma-net-profit/
DART. "Net Profit of Gc Pharma (Green Cross Corporation) from 2015 to 2021 (in Billion South Korean Won)." Statista, Statista Inc., 21 Mar 2022, https://www.statista.com/statistics/1165955/gc-pharma-net-profit/
DART, Net profit of GC Pharma (Green Cross Corporation) from 2015 to 2021 (in billion South Korean won) Statista, https://www.statista.com/statistics/1165955/gc-pharma-net-profit/ (last visited March 20, 2023)
Net profit of GC Pharma (Green Cross Corporation) from 2015 to 2021 (in billion South Korean won) [Graph], DART, March 21, 2022. [Online]. Available: https://www.statista.com/statistics/1165955/gc-pharma-net-profit/